Retension Pharmaceuticals Shares Fall After Nasdaq Debut

MT newswire2026/10/09 16:37

12:37 PM EDT, 10/09/2026 (MT Newswires) -- Retension Pharmaceuticals (RTSN) shares were down more than 11% in Friday trading after the company began trading on Nasdaq. The shares were trading at $10.64 after opening at $10 and reaching a high of $11.60. The company priced its initial public offering at $12 per share, expecting to raise $45 million in gross proceeds. The offering is expected to close Tuesday, Retension said late Thursday. Price: 10.64, Change: -1.37, Percent Change: -11.38

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Dow Jones Top Energy Headlines at 12 AM ET: Oil Futures Slide As Market Holds Out Hopes for Middle East Diplomacy | Energy ...

Dow Jones•2026/11/09 05:00

United States Dollar Index remains subdued as lower oil prices ease inflation pressure

FXStreet•2026/11/09 04:54

Citi is bullish on the Indian stock market, expecting the Nifty Index to rise to 28,000 points by the end of 2027.

路透社•2026/11/09 04:06

Silver Price Forecast: XAG/USD rises to near $53.00 as lower oil eases inflation pressure

FXStreet•2026/11/09 03:39